Tech Company Inital Public Offerings
Hyperion Therapeutics IPO
On 7/26/2012, Hyperion Therapeutics completed its IPO
Transaction Overview
Company Name
Announced On
7/26/2012
Transaction Type
IPO
Amount
$50,000,000
Proceeds Purpose
Proceeds purposes are on file with company statements at the SEC.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
601 Gateway Blvd 200
South San Francisco, CA 94080
USA
South San Francisco, CA 94080
USA
Phone
Website
Email Address
Overview
Hyperion Therapeutics, Inc. is a specialty biopharmaceutical company dedicated to improving patients' lives through the development and commercialization of therapies that address critical unmet needs and underserved patient populations. The Company's initial efforts are focused in the areas of gastroenterology and hepatology.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Don Santel
Chief Financial Officer
Jeffrey Farrow
Chief Medical Officer
Bruce Scharschmidt
Vice President
Christine Nash
VP - Bus. Development
Natalie Holles
VP - Regulatory Affairs
Ashley Gould
Browse more venture capital transactions:
Prev: 7/26/2012: Mitre Media venture capital transaction
Next: 7/26/2012: ExploraMed venture capital transaction
Share this article
Where The Data Comes From
We do our best to record funding rounds that are announced publicly. VC investment data records on this site are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs